Safety of influenza vaccination in patients with myasthenia gravis: A population-based study

Muscle and Nerve

Volumn 40, Issue 6, 2009, Pages 947-951

  Zinman, Lorne ^a,b   Thoma, Jessica ^b   Kwong, Jeffrey C ^b,c   Kopp, Alex ^c   Stukel, Thérèse A ^c,d   Juurlink, David N ^a,b,c,d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Influenza; Myasthenia gravis; Pharmacoepidemiology; Self matched designs; Vaccine safety

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CANADA; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENDER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; THYMECTOMY;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; GUILLAIN-BARRE SYNDROME; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; VACCINATION;

EID: 71549163451     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21440     Document Type: Article

References (17)

1. Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann NY Acad Sci 1981;377:670-677.
2. Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 1997;48:1253-1260. (Pubitemid 27240543)
3. Lacomis D. Myasthenic crisis. Neurocrit Care 2005;3:189-194.
4. Ropper AH, editor. Neurological and neurosurgical intensive care, 3rd ed. New York: Raven Press; 1993.
5. Domigo V, Authier FJ, Bachoud-Levi AC, Gherardi RK, Degos JD. Should hepatitis B vaccine be contra-indicated in myasthenia gravis?Autoimmunity 1999;29:139-140.
6. Biron P, Montpetit P, Infante-Rivard C, Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med 1988;148:2685. (Pubitemid 19048190)
7. Perez C, Maravi E. Polymyalgia rheumatica following influenza vaccination. Muscle Nerve 2000;23:824-825. (Pubitemid 30256618)
8. Blumberg S, Bienfang D, Kantrowitz FG. A possible association between influenza vaccination and small-vessel vasculitis. Arch Intern Med 1980;140:847-848. (Pubitemid 10120848)
9. Iyngkaran P, Limaye V, Hill C, Henderson D, Pile KD, Rischmueller M. Rheumatoid vasculitis following influenza vaccination. Rheumatology (Oxford) 2003;42:907-909. (Pubitemid 37220947)
10. Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, et al. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006;166:2217-2221. (Pubitemid 44748768)
11. Del Porto F, Lagana B, Biselli R, Donatelli I, Campitelli L, Nisini R, et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006;24:3217-3223.
12. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, et al. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007;56:1-54.
13. Kaminski HJ. What medications can be taken by people with myasthenia gravis? 2003. Available at: http://www.netwellness.org/healthtopics/gravis/box7. cfm#f. Accessed March 10, 2008.
14. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995;51:228-235.
15. Kwong JC, Manuel DG. Using OHIP physician billing claims to ascertain individual influenza vaccination status. Vaccine 2007;25:1270-1274.
16. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998;339:1797-1802.
17. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation [erratum in Am J Epidemiol 1998;147:93]. Am J Epidemiol 1996;143:1165-1173.